Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update

Go back to Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
Labranche & Co (NASDAQ: LAB) Delayed: 0.89 +0.03 (3.49%)
Previous Close $0.86    52 Week High $4.47 
Open $0.85    52 Week Low $3.02 
Day High $0.91    P/E N/A 
Day Low $0.85    EPS $-1.56 
Volume 958,500